Naproxen sodium, Pseudoephedrine HCl · NAPROXEN SODIUM 220 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 · Tablet, Film Coated, Extended Release · Oral · Cardinal Health 110, LLC. dba Leader
NDC 70000-0605-01 · 20 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 12% over the past year, to $0.2443 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Some pressure is visible, but not much — here’s everything the score found to count.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market · price up 7% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cardinal Health 110, LLC. dba Leader | NAPROXEN SODIUM 220 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Meijer Distribution Inc | NAPROXEN SODIUM 220 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates LLC | NAPROXEN SODIUM 220 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreen Company | NAPROXEN SODIUM 220 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Leader All Day Sinus and Cold D — NDC 70000-0605-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70000060501.
Free to cite with attribution — see how the data is put together.